Articles of note for people dealing with pituitary disease and related conditions.
The latest from pharmaceutical companies and healthcare organizations
Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
The science behind three-month Octreotide formulation
For those living with acromegaly, the daily challenges of managing their condition can be overwhelming. This podcast explores this new formulation of Octreotide that promises a significant shift in treatment protocols. With insights from Anne, we’ll dive into the details of this innovative approach, how it works, and why it matters for patients.
An important paper from Dr. Francesca Galbiati on hypothalamic obesity
HYPOTHALAMIC OBESITY: HOW TO HELP THE FIGHT AGAINST HUNGER-PROMOTING, EVOLUTIONARILY CONSERVED BRAIN NETWORKS From Francesca Galbiati, MD, neuroendocrinologist and neuroscientist,
Worth noting:
From Debiopharm, read about Oxtend™ 3 clinical trial for acromegaly for a long term (3-month) octreotide treatment. More information here.
From Camurus more information on a new treatment option for acromegaly. Read more here
From Crinetics Pharmaceuticals – FDA approves Crinetics PALSONIFY™ for adults with acromegaly . Read more
Recordati announces FDA approval of ISTURISA® new indication in the U.S. to treat endogenous hypercortisolemia in patients with Cushing’s syndrome,- Learn more here
New support site from Chiesi; Rethink acromegaly
Pfizer announces Together with Acromegaly patient support site.
Chiesi relaunches a patient-facing website for Mycapssa.
Content for physicians and healthcare professionals.
Join a drug trial. Find out how. Here’s a partial list of studies.
Latest trends and a roundup of health and wellness news
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D. Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Live Talk on Demand
In today’s podcast, Crinetics co-founders Dr. Scott Struthers and Dr. Steve Betz share their views and experiences in drug discovery and development, revealing what it really takes to bring a new medication from concept to patients.
In the latest episode of the Pituitary World News podcast, Jorge D. Faccinetti sits down with Dr. Markus Johnsson, Senior VP of R&D at Camurus, to explore the fascinating world of FluidCrystal® technology. This innovative approach promises to revolutionize the way we think about drug delivery, providing long-lasting solutions for chronic diseases particularly for people with acromegaly.
Apple Podcasts
Spotify
Amazon Music
Google PodcastsEvents
Save the date!
